US doctor warns of many undiagnosed polio cases

August 9, 2022
Manufacturing and Production

A doctor in New York State has warned that there could be hundreds, or even thousands, of undiagnosed cases of …

FDA approves Myovant Sciences and Pfizer’s treatment for endometriosis pain

August 9, 2022
Manufacturing and Production

The FDA has approved MYFEMBREE as a one-pill, once-a-day therapy for the management of moderate to severe pain associated with …

SMC accepts first licensed treatment for newly diagnosed AL amyloidosis

August 9, 2022
Manufacturing and Production

The SMC has accepted the first licensed treatment for adults with newly diagnosed systemic light chain (AL) amyloidosis. Darzalex® (daratumumab) …

Patients’ cancers should be genetically profiled to improve care, health experts say

August 9, 2022
Manufacturing and Production

A consensus group of leading experts have shared that the NHS should offer all cancer patients genetic profiling of their …

HUTCHMED’s metastatic colorectal cancer treatment meets primary endpoint in Phase III trial

August 8, 2022
Sales and Marketing

HUTCHMED has announced that its global Phase III FRESCO-2 trial, evaluating the investigational use of fruquintinib, reached its primary endpoint …

Another “Winter crisis” on horizon for NHS without urgent action

August 8, 2022
Sales and Marketing

The NHS in England could face “very serious challenges coming down the track” without significant action tackling the emergency crisis …

SIGA will seek FDA approval of monkeypox treatment once data is available

August 8, 2022
Sales and Marketing

The CEO of SIGA Technologies has announced that they are planning to ask the FDA for approval and authorisation for …

Melanoma cells use ‘molecular drills’ to invade new tissues, research finds

August 8, 2022
Sales and Marketing

Scientists have identified a nerve cell gene that enables melanoma cells to branch out and invade new tissues. Research from …

F2G announce development and commercialisation for rare antifungal treatment

August 5, 2022
Medical Communications

F2G, a clinical-stage biopharmaceutical company, has announced that it can now soon bring a fourth antifungal class to the market. …

Societal CDMO wins tech transfer and production contract for HIV drug candidate

August 5, 2022
Medical Communications

Societal CDMO, a contract development and manufacturing organisation (CDMO) has been selected to provide CDMO services to support the ongoing …

Over 100,000 monkeypox vaccines procured, according to government

August 4, 2022
Business Services

Over 100,000 doses of the monkeypox vaccine have been acquired in order to combat the spread of the virus, the …

UK health officials identify new symptoms of monkeypox

August 4, 2022
Business Services

Health officials have identified a number of new monkeypox symptoms following the news that the outbreak was now a “public …

Medics in Ukraine work amid shelling and worsening health crisis

August 4, 2022
Business Services

Ukraine’s health emergency is worsening WHO have shared, as the conflict with Russia continues, and staff face burnout and increased …

NHS screening pilot for Hepatitis C

August 4, 2022
Business Services

Thousands will receive potentially life-saving treatment for Hepatitis C from the NHS, under a screening pilot. This is part of …

Fourth and oldest patient to be cured of HIV

July 28, 2022
Business Services

A 66 year old man has become the fourth person to be effectively cured of HIV infection following a stem …

Global monkeypox cases rise to 18,000

July 28, 2022
Business Services

WHO have shared that the window to stop the spread of monkeypox is closing, with cases currently doubling every two …

PCI Pharma Services announces multi-million dollar expansion to UK manufacturing facility

July 27, 2022
Research and Development

PCI has announced a significant expansion of its facility in Tredegar, Wales, UK, designed to help keep up to date …

Micronesia’s first COVID outbreak sees steep rise in cases

July 27, 2022
Research and Development

Micronesia’s first outbreak of COVID-19 has grown in one week to over 1,000 cases, causing significant alarm in the Pacific …

Updated NICE pre-eclampsia guidance

July 27, 2022
Research and Development

New NICE guidance has been released, recommending the routine use of placental growth factor (PIGF), based on testing in the …

MHRA grant marketing authorisation for sickle cell anaemia treatment

July 26, 2022
Manufacturing and Production

Global Blood Therapeutics (GBT) has announced the MHRA marketing authorisation for Oxbryta® (voxelotor) for the treatment of haemolytic anaemia due …

The Gateway to Local Adoption Series

Latest content